SD BIOSENSOR INC.: debt-to-equity, ROE and more
KOSPI, Legal name SD BIOSENSOR INC.
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 38.8%
- Equity ratio
- 72.1%
- ROE
- -22.0%
- Op. margin
- -11.4%
- Rev. growth
- 2.3%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 3 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
| Fiscal year | Cash dividend per share | Payout ratio |
|---|---|---|
| 2025 | ₩200 | n/a |
| 2024 | ₩200 | n/a |
| 2023 | n/a | n/a |
Cash dividends for 2 straight years (only the 3 years OpenDART returns).
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 consolidated | 36.4% | 73.3% | 48.3% | 46.6% | n/a |
| FY2022 consolidated | 10.7% | 90.3% | 30.8% | 39.1% | 0.1% |
| FY2023 consolidated | 33.8% | 74.7% | -16.5% | -37.8% | -77.6% |
| FY2024 consolidated | 32.6% | 75.4% | -3.3% | -7.8% | 5.9% |
| FY2025 consolidated | 38.8% | 72.1% | -22.0% | -11.4% | 2.3% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩2.93T | ₩2.93T | ₩655.7B | ₩694.6B | ₩710.6B |
| Operating profit | ₩1.36T | ₩1.15T | -₩248.1B | -₩54.1B | -₩80.9B |
| Pre-tax income | ₩1.44T | ₩1.24T | -₩438.6B | -₩219.2B | -₩918.1B |
| Net income | ₩1.06T | ₩908.8B | -₩467.9B | -₩98.1B | -₩513.4B |
| Total assets | ₩3.01T | ₩3.26T | ₩3.79T | ₩3.89T | ₩3.24T |
| Total liabilities | ₩801.7B | ₩315.1B | ₩957.3B | ₩956.2B | ₩905.9B |
| Total equity | ₩2.20T | ₩2.95T | ₩2.83T | ₩2.93T | ₩2.34T |
| Paid-in capital | ₩51.6B | ₩52.2B | ₩62.2B | ₩62.2B | ₩62.2B |
| Debt/equity (source value) | 36.4% | 10.7% | 33.8% | 32.6% | 38.8% |
Company outline (FSC)
- Market
- KOSPI
- Fiscal year end
- Dec
- Founded
- 2010-12-27
- Listed
- 21/07/16
- Employees
- 656
- Auditor
- 삼일회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1358110191121
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 에스디바이오센서Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.